@MisterMister I have no problems with your views on governance (although I do not necessarily share your views) but these issues are rectifiable. I am encouraged that you acknowledge that PAR may have a good product but I would like to hear your response as to how a treatment of iPPS can last 3.5 years (and longer), with no other pain relief drugs, without being disease modifying. Perhaps some further consideration may lead you to strengthen your opinion as to how effective iPPS is with a proven safety profile.
@MisterMister I have no problems with your views on governance...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |